Oura Ring Just Connected to Xella's Women's Health Platform — This Is What Clinical Interpretation of Wearable Data Actually Looks Like
Xella now pulls Oura Ring sleep, HRV, and temperature data into clinical interpretation alongside hormone tests, covering 130+ female-specific conditions.
Peter Attia on Thyroid Health: Why 5% of Adults Are Mismanaged, TSH Isn't the Full Picture, and What to Do When Tests Look Normal But You Don't
In AMA #89, Peter Attia addresses thyroid dysfunction — one of medicine's most commonly mismanaged conditions. TSH measures pituitary signaling, not tissue-level T3 activity. He stakes out the messy middle between under-treatment and over-treatment camps, with a framework for evaluating subclinical dysfunction and persistent symptoms with normal tests.
Peter Attia Episode 404: Why the Neurotransmitter Model of Mental Health Is Incomplete
Dr. Linus Abrams argues that psychiatry's focus on symptom reduction through medication overlooks the hormonal, metabolic, and inflammatory drivers of mental health. The implications for how practitioners and patients think about mental wellbeing are significant.
Menopause Is a Muscle-Health Inflection Point — and Most Programs Miss It
Estrogen decline during menopause narrows the window for muscle protein synthesis and changes how training responds. The intervention stack is specific: protein distribution, progressive resistance, and individualized HRT consideration — not just more of each.
5 Perimenopause Supplements That Actually Hold Up: Evidence-Graded and Label-Checked
Most perimenopause supplement blends are under-dosed marketing. This evidence-graded breakdown identifies five options that hold up on clinical data, labeled doses, and standardized extracts.
5 Perimenopause Supplements That Hold Up: Evidence-Graded and Label-Checked
Most perimenopause supplement blends are underdosed and opaque. This evidence-graded breakdown applies clinical trial dosing standards to the current field — here are the five that survive scrutiny.
Does Losing Sleep Mean Losing Lifespan? What the Meta-Analysis Can't Tell You
A new 79-study meta-analysis links short sleep to 14% higher mortality — but Peter Attia identifies a fundamental problem with the data. Here's what the observational evidence actually proves, and what the controlled research says instead.
Menopause Tracking: Why the Average Is 9 Symptoms, Not 1 or 2
A Winona study of 100,000+ women found an average of nine simultaneous menopause symptoms — and 77.5% waited over a year before accessing care. The data reframes how practitioners should think about this life stage.
Clair Raises $11.6M to Build the First Continuous Hormone Monitor for Women
Clair's wrist-worn device uses 10 biosensors and 130+ proprietary biomarkers to infer estrogen, progesterone, LH, and FSH levels in real time — revealing 9 distinct hormonal sub-phases the traditional 4-phase model misses.
Growth Hormone for Injury Recovery: The Evidence Gap Between Clinics and Clinical Trials
hGH reliably raises IGF-1. IGF-1 drives anabolic signaling. Somewhere between that mechanism and the recovery outcomes being sold in wellness clinics, the evidence breaks down.
Ultra-Processed Foods Cut Sperm Motility 18% in Just Three Weeks
3 weeks of ultra-processed food cut sperm motility 18% and testosterone 11% in a controlled trial — without eating extra calories. The mechanism matters.
MBX 4291 Monthly GLP-1 Shows 7% Weight Loss at Eight Weeks
MBX 4291 hit 7% weight loss at 8 weeks with a 26-day half-life supporting true once-monthly dosing — and Phase 1 data shows no serious safety signals.
Function Health: The Case for Testing Insulin Before You Need To
Function Health offers 160+ lab tests covering metabolic and hormonal markers that standard care skips — here's what the extra data actually tells you.